Our Commitment

At Australian Pericardium Solutions, we are committed to exporting premium Australian bovine pericardium worldwide. Our high-quality biomaterials, offer exceptional strength and elasticity, ideal for applications in bio-prosthetic heart valves, surgical reinforcement, and tissue regeneration. We uphold rigorous quality and compliance standards to ensure our products meet global regulatory requirements.

With a strategic trading and manufacturing partnership in China, we have established local facilities to serve this vital market and enhance our global distribution capabilities. Our dedication to innovation and collaboration with leading medical institutions enables us to deliver superior, biocompatible solutions that advance regenerative medicine and medical device manufacturing. The market for bovine pericardium, including bobby veal, is expanding significantly, with high demand in cardiovascular, dental, and reconstructive surgeries, projected to reach billions in value as medical applications continue to grow.

Powered by Excellence

APS is built on a team of MedTech professionals with decades of global market leading experience with international experts across every function of its C-suite.

Discover More

Professor Ian Meredith director of Monash heart for 12 years and Chief Medical Officer Boston Scientific 2017 to 2023.

The measure of any successful business is the quality of its people. APS has assembled a team with exceptional knowledge and standalone experience across all facets that will create sustainable value to shareholders and facilitate the secure growth of this market leading MedTech enterprise.

Professor Ian Meredith,
AM Chief Medical Officer
Australian Pericardium Solutions

Discover More